Ophthalmology, Retina Specialist · Marion, IL
NPI
1154543916
Since 2007
Specialty
Ophthalmology, Retina Specialist
Code 207WX0107X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1200 W Deyoung St
Marion, IL, 62959
Phone (618) 993-5686
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.8M
37,773 services
Medicare patients, 2024
1,679
Average age 73
Drug cost, 2024
$194K
8,557 prescriptions
Company payments, 2025
$79.28
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Faisel Ahmad was code J2777 (injection, faricimab-svoa, 0.1 mg), 28,620 times for 112 patients. In total Faisel Ahmad billed 37,773 services in 70 codes, and Medicare paid $1.8M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2777 Injection, faricimab-svoa, 0.1 mg | Office | 28,620 | 112 | $27.47 | $786K |
| 92136 Ultrasound - Nonspecific | Office | 1,439 | 843 | $16.66 | $24K |
| 66984 Cataract Surgery | Facility | 1,430 | 789 | $395.17 | $565K |
| 92014 Ophthalmological E&M | Office | 1,336 | 1,153 | $76.95 | $103K |
| 92134 Computerized Ophthalmic Imaging | Office | 1,305 | 898 | $26.67 | $35K |
| 92012 Ophthalmological E&M | Office | 452 | 220 | $58.81 | $27K |
| 67028 Intravitreal Injection | Office | 411 | 126 | $91.52 | $38K |
| 66821 Cataract Surgery | Office | 360 | 355 | $336.42 | $121K |
| 92202 Ophthalmological E&M | Office | 146 | 137 | $9.94 | $1,452 |
| 92004 Ophthalmological E&M | Office | 131 | 131 | $78.30 | $10K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 96 | 15 | $0.75 | $71.58 |
| 92133 Computerized Ophthalmic Imaging | Office | 49 | 47 | $24.63 | $1,207 |
| 66991 Cataract Surgery | Facility | 42 | 26 | $496.29 | $21K |
| 92083 Vision, Hearing, and Speech Services | Office | 41 | 37 | $42.93 | $1,760 |
| 65855 Fluid Flow and Drainage of Eye (Any Method) | Office | 28 | 28 | $252.74 | $7,077 |
By year: 2022 $1.7M for 9,784 services; 2023 $1.6M for 15,972 services; 2024 $1.8M for 37,773 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83861 Clinical Chemistry | 29 | 14 | $22.03 | $639 |
Medicare prescription drug claims, 2024
In 2024, the drug Faisel Ahmad prescribed most often to Medicare patients was Prednisolone Acetate, with 2,618 prescriptions and refills. In total Faisel Ahmad wrote 8,557 Medicare prescriptions that cost $194K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisolone Acetate Generic | 2,618 | 2,738 | 1,583 | $66K |
| Ketorolac Tromethamine Generic | 2,008 | 2,106 | 1,207 | $31K |
| Ciprofloxacin Hcl Generic | 1,304 | 1,360 | 802 | $15K |
| Tobramycin Generic | 687 | 709 | 413 | $3,194 |
| Diclofenac Sodium Generic | 547 | 565 | 350 | $5,099 |
| Moxifloxacin Moxifloxacin Hcl | 497 | 498 | 287 | $15K |
| Latanoprost Generic | 237 | 312 | 59 | $1,523 |
| Ofloxacin Generic | 126 | 135 | 83 | $1,341 |
| Doxycycline Hyclate Generic | 55 | 69 | 20 | $3,447 |
| Timolol Maleate Generic | 51 | 94 | 14 | $1,001 |
| Brimonidine Tartrate Generic | 48 | 72 | 15 | $2,052 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 36 | 36 | 33 | $406 |
| Cyclosporine Generic | 34 | 46 | 12 | $8,422 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 33 | 53 | Under 11 | $361 |
| Restasis Cyclosporine | 20 | 22 | Under 11 | $14K |
Brand drugs: 3,807 claims; generic drugs: 4,750 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Faisel Ahmad $79.28 ($79.28 in general payments such as food, travel and fees) from 2 companies. The largest payer was Alcon Vision LLC with $45.57.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.